In vitro testing of Innovation Pharmas’ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
-
-
Regeneron announced manufacturing and supply agreement for BARDA and U.S. DoD for REGN-COV2 anti-viral antibody cocktail
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
-
Corvus Pharmaceuticals initiated clinical trial of novel immunotherapy for patients with COVID-19
On Jul. 7, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
-
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
-
Anixa Biosciences and OntoChem announced completion of initial screening program and identification of additional Covid-19 compounds
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
-
Biotechnology | COVID-19 | Disease | HIV | Infectious Disease | Therapeutics | WHO
Access to HIV medicines severely impacted by COVID-19 as AIDS response stalled
On Jul. 6, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
-
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced an update to its previously announced partnership with Butantan, a leading…
-
WHO discontinued hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
On Jul. 4, 2020, the World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering…
-
CytoDyn announced exclusive agreement for distribution and supply of leronlimab for treatment of COVID-19 in U.S.
On Jul. 3, 2020, CytoDyn announced it had signed an exclusive Distribution and Supply Agreement with American Regent…
-
Biotechnology | FDA | HIV | Therapeutics
The FDA approved new HIV treatment for patients with limited treatment options
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
-
FDA issued Emergency Use Authorization for Philips’ acute care patient monitoring solutions for hospitals
On Jul. 2, 2020, Royal Philips announced that the U.S. Food and Drug Administration (FDA) had issued an…
-
UConn-made COVID-19 custom mask solution to be manufactured
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
-
Biotechnology | FDA | HIV | Therapeutics
ViiV Healthcare announced FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the US Food…
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
-
Fujifilm partnered with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
On Jul. 1, 2020, FUJIFILM announced a partnership with Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in…
-
MediciNova announced IND for MN-166 (ibudilast) for prevention of ARD Syndrome in patients with COVID-19
On Jul. 1, 2020, MediciNova announced that the Investigational New Drug Application (IND) for MN-166 (ibudilast) for prevention…
-
OPKO Health’s BioReference Laboratories reports results of COVID-19 testing for almost one quarter of a million nursing home employees
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
-
Gilead Sciences announced Covid-19 drug Remdesivir to cost $3,120 for typical patient on private insurance
On Jun. 29, 2020, Remdesivir, the investigational drug for the treatment of the coronavirus disease 2019 (COVID-19), will…
-
Association between statewide school closure and COVID-19 incidence and mortality in the US
On Jun. 29, 2020, a study published in JAMA showed that in the U.S., states enacted nonpharmaceutical interventions,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
-
Altimmune received award from US DoD to fund phase 1/2 clinical trial of T-COVID in outpatients with early COVID-19
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
-
LabCorp introduced Xcellerate COVID-19 clinical study solution
On Jun. 29, 2020, LabCorp announced that Covance, its drug development business, has deployed the Xcellerate COVID-19 solution…
-
Biotechnology | COVID-19 | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
-
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine has been selected to participate in a…
-
CIRM board approved third clinical trial for COVID-19
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
-
University of Alberta researcher to test whether COVID-19 antibodies provide long-term immunity
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
-
The FDA approved new therapy for Dravet Syndrome
On Jun. 25, 2020, the U.S. Food and Drug Administration (FDA) approved Fintepla (fenfluramine), a Schedule IV controlled…
-
Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
-
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
